Ashita M. Waterston
Glasgow, SCT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Artificial Intelligence-Enhanced Electrocardiography for Prediction of Cancer Therapy-Related Cardiac Dysfunction.
Journal: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
Published: April 07, 2026
Three Versus 6 Months of Adjuvant Oxaliplatin-Fluoropyrimidine Chemotherapy for Colorectal Cancer: Final Results of SCOT-An International, Randomized, Phase III, Noninferiority Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 09, 2026
Prospective Evaluation of the Cardiovascular Effects of BRAF and MEK Inhibitors in Patients With Melanoma.
Journal: JACC. CardioOncology
Published: April 09, 2025
A randomised phase 2 study of intermittent versus continuous dosing of dabrafenib plus trametinib in patients with BRAFV600 mutant advanced melanoma (INTERIM).
Journal: European journal of cancer (Oxford, England : 1990)
Published: September 05, 2023
Real-world effectiveness of systemic anticancer therapy for advanced melanoma in the west of Scotland from 2010 to 2018.
Journal: Future oncology (London, England)
Published: April 11, 2023
Consensus statement for metastatic surveillance of uveal melanoma in Scotland.
Journal: Eye (London, England)
Published: February 27, 2022
Mechanistic and Clinical Overview Cardiovascular Toxicity of BRAF and MEK Inhibitors: JACC: CardioOncology State-of-the-Art Review.
Journal: JACC. CardioOncology
Published: October 31, 2021
Challenging presentations of germ cell tumours in routine clinical practice.
Journal: The journal of the Royal College of Physicians of Edinburgh
Published: April 20, 2021
Comprehensive Characterization of the Vascular Effects of Cisplatin-Based Chemotherapy in Patients With Testicular Cancer.
Journal: JACC. CardioOncology
Published: January 15, 2020
3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCT.
Journal: Health technology assessment (Winchester, England)
Published: December 20, 2019
Last Updated: 09/26/2026